Retractable Technologies, Inc. (NYSE:RVP – Get Rating) shares were down 2.9% on Friday . The company traded as low as $4.64 and last traded at $4.74. Approximately 58,718 shares were traded during mid-day trading, a decline of 64% from the average daily volume of 164,518 shares. The stock had previously closed at $4.88.
Wall Street Analysts Forecast Growth
Separately, StockNews.com lowered shares of Retractable Technologies from a “buy” rating to a “hold” rating in a report on Thursday, May 12th.
Retractable Technologies Stock Performance
The company has a current ratio of 3.75, a quick ratio of 3.08 and a debt-to-equity ratio of 0.02. The firm has a market cap of $156.12 million, a P/E ratio of 3.56 and a beta of 1.95. The company has a fifty day moving average price of $4.30.
About Retractable Technologies
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
- Get a free copy of the StockNews.com research report on Retractable Technologies (RVP)
- MarketBeat: Week in Review 7/25 – 7/29
- Procter’s Earnings Start To Show Weakness In Q4
- The One Question You Have to Ask Before Investing in INTC Stock
- Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
- Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.